25TH-26TH SEPTEMBER 2024 | MÖVENPICK HOTEL | BASEL | SWITZERLAND

Cantoni Therapeutics is a private pharmaceutical company based in Leiden, the Netherlands dedicated to the discovery, development and commercialization of first-in-class small molecule inhibitors towards Nicotinamide N-methyltransferase, NNMT, a promising and novel target for cardiometabolic disease. Meet Cantoni Therapeutics BV @ hashtag#Sachs_BEF More Info @ https://lnkd.in/d7zEuKym